Myotonic dystrophy type 1 study

Myotonic dystrophy type 1 study (triplet repeat expansion analysis)

[DMPK]

TOURNAROUND TIME: 6 WEEKS

Myotonia refers to a neurological symptom that describes difficulty in muscle relaxation after contraction. There may be an involvement pattern, although any muscle group can be affected.
Among hereditary myotonias, there are mainly two groups:

  • Dystrophic myotonia (or myotonic dystrophy, whose main form is also known as DM1 or Steinert disease): Its prevalence is estimated to be about 1/8 000 individuals. Clinically, it is a multisystem disease where myotonia is accompanied by muscle weakness, cardiac conduction problems, cataracts, and endocrine and gastrointestinal alterations. Its molecular mechanism consists of a trinucleotide expansion in the DMPK gene; therefore, its diagnosis requires a specific test.
  • Non-dystrophic myotonias belong to the group of channelopathies, and their genetic defect determines the occurrence of symptoms including myotonia as well as weakness, myalgias, episodes of paralysis, etc.
REFERENCES
  1. Udd B, Krahe R. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol 2012; 11:891.
  2. Miller TM. Differential diagnosis of myotonic disorders. Muscle Nerve 2008; 37:293

 

NEUROLOGY PORTFOLIO


STUDY REQUEST
Select the panel you wish to request


INFORMED CONSENT
Required document in order to perform the study


VARIANT CLASSIFICATION
Variant classification and clinical usefulness criteria

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información